Acne Medication Market, by Drug Class (Retinoid (Topical Retinoid and Oral Retinoid), Antibiotics (Topical Antibiotics and Oral Antibiotics), Fixed Dose Combinations (Clindamycin + Benzoyl Peroxide, Clindamycin + Tretinoin, Adapalene + Benzoyl Peroxide, T

Acne Medication Market, by Drug Class (Retinoid (Topical Retinoid and Oral Retinoid), Antibiotics (Topical Antibiotics and Oral Antibiotics), Fixed Dose Combinations (Clindamycin + Benzoyl Peroxide, Clindamycin + Tretinoin, Adapalene + Benzoyl Peroxide, Tretinoin + Benzoyl Peroxide and Others), Salicylic Acid, Azelaic Acid, Benzoyl Peroxide and Others), by Type (Prescription and OTC), by Indication (Inflammatory Acne and Non-Inflammatory Acne), by Formulation (Topical Medication and Oral Medication), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It results in pimples, blackheads, or whiteheads. Although, it can afflict anyone at any age, acne is most prevalent in teenagers. The lumps and pimples heal slowly, and just as one starts to go, another one seems to appear. Depending on how severe it is, acne can leave skin scars and create emotional distress. Acne treatments function by lowering sebum production, curing bacterial infections, and/or reducing swelling. Sebum produced by the sebaceous glands in healthy skin is released onto the skin's surface through the pore, a follicular opening. The follicle is lined with keratinocytes, a kind of skin cell. The keratinocytes normally ascend to the skin's surface during skin cell shedding. Hair, sebum, and keratinocytes clump together in the pore of an acne patient. As a result, the keratinocytes are kept from shedding and sebum is kept from penetrating the skin's surface. Inflammation, including swelling, redness, heat, and pain, is brought on by bacteria that ordinarily reside on the skin and can proliferate in clogged follicles when oil and cells are present.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as product is expected to drive market growth over the forecast period. For instance, in March 2022, Galderma, a pharmaceutical company, announced the U.S. launch of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3%, during the American Academy of Dermatology (AAD) Annual Meeting, held during March 25-29, 2022, in Boston, Massachusetts. The first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 formulation that has been shown to effectively treat moderate to severe face acne is TWYNEO Cream.

Key features of the study:

• This report provides an in-depth analysis of the global acne medication market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global acne medication market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global acne medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne medication market

Detailed Segmentation:

• Global Acne Medication Market, By Drug Class:
• Topical Retinoid
• Oral Retinoid
• Topical Antibiotics
• Oral Antibiotics
• Clindamycin + Benzoyl Peroxide
• Clindamycin + Tretinoin
• Adapalene + Benzoyl Peroxide
• Tretinoin + Benzoyl Peroxide
• Others
• Retinoid
• Antibiotics
• Fixed Dose Combinations
• Salicylic Acid
• Azelaic Acid
• Benzoyl Peroxide
• Others
• Global Acne Medication Market, By Type:
• Prescription
• OTC
• Global Acne Medication Market, By Indication:
• Inflammatory Acne
• Non-Inflammatory Acne
• Global Acne Medication Market, By Formulation:
• Topical Medication
• Oral Medication
• Global Acne Medication Market, By Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Global Acne Medication Market, By Region:
• North America

By Country

• U.S.
• Canada
• Latin America

By Country

• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe

By Country

• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific

By Country

• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East

By Country

• GCC
• Israel
• Rest of Middle East
• Africa

By Region/Country

• South Africa
• Central Africa
• North Africa
• Company Profiles
• Galderma Laboratories, L.P.*

Company Highlights

Products Portfolio

Key Highlights

Financial Performance

Strategies

• Reckitt Benckiser Group PLC.
• Bausch Health Companies Inc.
• GlaxoSmithKline plc.
• Arctic Therapeutics International
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Biopharmx, Inc.
• Paratek Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
• F.Hoffmann-La Roche Ltd

“*” marked represents similar segmentation in other categories in the respective section.